#######################
# Document Properties #
#######################
SET DOCUMENT Copyright   = "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved."
SET DOCUMENT Licenses    = "CC BY 4.0"
SET DOCUMENT ContactInfo = "charles.hoyt@scai.fraunhofer.de"

SET DOCUMENT Name        = "Hypoxia Inducible Factor-1 as a Target for Neurodegenerative Diseases."
SET DOCUMENT Version     = "1.0.0"
SET DOCUMENT Authors     = "Yojana Gadiya"
SET DOCUMENT Description = ""

##############
# Namespaces #
##############

# Namespaces hosted on https://github.com/pharmacome/conso
# --------------------------------------------------------
 DEFINE NAMESPACE CHEBI          AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns"
# DEFINE NAMESPACE CONSO          AS URL "https://raw.githubusercontent.com/pharmacome/conso/4aa36980578c7d2cff07371abf768f15db89cd11/export/conso-names.belns"
# DEFINE NAMESPACE DRUGBANK       AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/drugbank-names.belns"
# DEFINE NAMESPACE DOID           AS URL "https://raw.githubusercontent.com/pharmacome/conso/c0c576e3d3ab9b25a3982251a4ee2fd7c49e1679/external/doid-names.belns"
# DEFINE NAMESPACE ECCODE         AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/ec-code.belns"
# DEFINE NAMESPACE EFO            AS URL "https://raw.githubusercontent.com/pharmacome/conso/5d2c2ea6f7112421cc8089a3f021a75ab60bb373/external/efo-names.belns"
# DEFINE NAMESPACE FB             AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/fb-names.belns"
DEFINE NAMESPACE HGNC           AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns"
 DEFINE NAMESPACE HGNCGENEFAMILY AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc.genefamily-names.belns"
# DEFINE NAMESPACE HP             AS URL "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/hp-names.belns"
 DEFINE NAMESPACE GO             AS URL "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/go-names.belns"
# DEFINE NAMESPACE INTERPRO       AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/interpro-names.belns"
 DEFINE NAMESPACE MESH           AS URL "https://raw.githubusercontent.com/pharmacome/conso/f02c6ad4a4791a8ed45448513b9de8c8f1b00c87/external/mesh-names.belns"
# DEFINE NAMESPACE MGI            AS URL "https://raw.githubusercontent.com/pharmacome/conso/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/mgi-names.belns"
# DEFINE NAMESPACE MIRBASE        AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/mirbase-names.belns"
# DEFINE NAMESPACE NCBIGENE       AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/ncbigene.belns"
 DEFINE NAMESPACE PFAM           AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/pfam-names.belns"
# DEFINE NAMESPACE RGD            AS URL "https://raw.githubusercontent.com/pharmacome/conso/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/rgd-names.belns"

# Namespaces hosted on https://github.com/sorgerlab/famplex
# ---------------------------------------------------------
# DEFINE NAMESPACE FPLX           AS URL "https://raw.githubusercontent.com/sorgerlab/famplex/d9ec0526c20795146a9a6aef17496efe1a36cac6/export/famplex.belns"

# Namespaces defined with regular expressions
# -------------------------------------------
# DEFINE NAMESPACE DBSNP          AS PATTERN "rs[0-9]+"
# DEFINE NAMESPACE TAXONOMY       AS PATTERN "^\d+$"
# DEFINE NAMESPACE UNIPROT        AS PATTERN "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\.\d+)?$"
# DEFINE NAMESPACE PUBCHEM        AS PATTERN "^\d+$"
 DEFINE NAMESPACE NCIT           AS PATTERN "^C\d+$"
###############
# Annotations #
###############

# Annotations defined with regular expressions
# --------------------------------------------
DEFINE ANNOTATION Species       AS PATTERN "^\d+$"

# Annotations hosted on https://arty.scai.fraunhofer.de/artifactory/bel/annotation
# --------------------------------------------------------------------------------
# DEFINE ANNOTATION Anatomy       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno"
# DEFINE ANNOTATION CellLine      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno"
# DEFINE ANNOTATION CellStructure AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno"
# DEFINE ANNOTATION Cell          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno"
# DEFINE ANNOTATION Confidence    AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
# DEFINE ANNOTATION Disease       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno"
# DEFINE ANNOTATION Gender        AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno"
# DEFINE ANNOTATION MeSHAnatomy   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
 DEFINE ANNOTATION MeSHDisease   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
# DEFINE ANNOTATION Subgraph      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno"
# DEFINE ANNOTATION TextLocation  AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"

##############
# Statements #
##############
SET Citation = {"PubMed", "21861815"}

SET Evidence = "HIF-1 is a heterodimetric complex consisting of a constitutively expressed β subunit (also
known as the aryl hydrocarbon receptor nuclear translocation, ARNT) and a hypoxia
inducible subunit, α subunit [2]."
complex(MESH:"Hypoxia-Inducible Factor 1") hasComponents list(p(HGNC:HIF1A),p(HGNC:ARNT))

SET Evidence = "The bHLH and PAS motifs are required for dimerization between HIF-1α and HIF-1β."
#bHLH - basic helix-loop-helix
#PAS - PER-ARNT-SIM
p(HGNCGENEFAMILY:"Basic helix-loop-helix proteins") -> complex(MESH:"Hypoxia-Inducible Factor 1")
p(PFAM:PAS) -> complex(MESH:"Hypoxia-Inducible Factor 1")

SET Evidence = "Under hypoxia, HIF-1α is stabilized and translocated to the nucleus where it dimerizes with HIF-1β
[3]."
bp(GO:"response to hypoxia") -> tloc(p(HGNC:HIF1A),fromLoc(GO:cytoplasm),toLoc(GO:nucleus))
p(HGNC:HIF1A,loc(GO:nucleus)) -> complex(p(HGNC:HIF1A),p(HGNC:ARNT),loc(GO:nucleus))
complex(p(HGNC:HIF1A),p(HGNC:ARNT),loc(GO:nucleus)) -> act(complex(MESH:"Hypoxia-Inducible Factor 1"))

SET Evidence = "The activated HIF-1 complex subsequently binds to hypoxic response elements (HREs)
in the regulatory regions of genes and recruits co-transactivation factors such as CBP/p300
[CBP: CREB (cAMP-response element-binding protein)-binding protein/E1A-binding
protein]."
#NCIT:C13718 - HRE
complex(complex(MESH:"Hypoxia-Inducible Factor 1"),p(NCIT:C13718)) -> p(HGNC:CREBBP)
complex(complex(MESH:"Hypoxia-Inducible Factor 1"),p(NCIT:C13718)) -> p(HGNC:EP300)

SET Evidence = "The activity of HIF-1 is mainly controlled through regulating the protein level of HIF-1α [3]."
p(HGNC:HIF1A) reg act(complex(MESH:"Hypoxia-Inducible Factor 1"))

SET Evidence = "The hydroxylation is mediated by a family of prolyl hydroxylases, namely PHD1,
PHD2, and PHD3 [12], among which PHD2 has the highest specificity for hydroxylation of HIF-1α [11]."
#prolyl residue 402,546
p(HGNC:EGLN2) -> p(HGNC:HIF1A,pmod(Hy,Pro,402))
p(HGNC:EGLN2) -> p(HGNC:HIF1A,pmod(Hy,Pro,546))
p(HGNC:EGLN1) -> p(HGNC:HIF1A,pmod(Hy,Pro,402))
p(HGNC:EGLN1) -> p(HGNC:HIF1A,pmod(Hy,Pro,546))
p(HGNC:EGLN3) -> p(HGNC:HIF1A,pmod(Hy,Pro,402))
p(HGNC:EGLN3) -> p(HGNC:HIF1A,pmod(Hy,Pro,546))

SET Evidence = "These PHD enzymes are 2-oxoglutarate-dependent dioxygenases and require oxygen as well as Fe2+ as cofactors [13–14]."
composite(a(CHEBI:"2-oxoglutarate(1-)"),a(CHEBI:dioxygen),a(CHEBI:"iron(2+)")) -> act(p(HGNC:EGLN2))
composite(a(CHEBI:"2-oxoglutarate(1-)"),a(CHEBI:dioxygen),a(CHEBI:"iron(2+)")) -> act(p(HGNC:EGLN1))
composite(a(CHEBI:"2-oxoglutarate(1-)"),a(CHEBI:dioxygen),a(CHEBI:"iron(2+)")) -> act(p(HGNC:EGLN3))

SET Evidence = "Hydroxylation promotes interaction of HIF-1α with the von Hippel-Lindau (pVHL)
ubiquitin E3 ligase complex [15–16]. HIF-1α is thereby poly-ubiquitinated and degraded by the 26S proteasome [17–18]."
#NCIT:C13970 - 26S proteasome
p(HGNC:HIF1A,pmod(Hy,Pro,402)) -> complex(p(HGNC:VHL),p(HGNC:HIF1A))
p(HGNC:HIF1A,pmod(Hy,Pro,402)) -> complex(p(HGNC:VHL),p(HGNC:HIF1A))
complex(p(HGNC:VHL),p(HGNC:HIF1A)) -> p(HGNC:HIF1A,pmod(Ub))
p(HGNC:HIF1A,pmod(Ub)) -> composite(p(HGNC:HIF1A,pmod(Ub)),p(NCIT:C13970))
composite(p(HGNC:HIF1A,pmod(Ub)),p(NCIT:C13970)) -> deg(p(HGNC:HIF1A)

SET Evidence = "Since the PHDs employ non-heme iron
in the catalytic moiety, it can be predicted that shortage of intracellular iron will
result in inhibition of activity of PHDs and HIF-1 upregulation."
a(CHEBI:"iron chelator") -| p(HGNC:EGLN2)
a(CHEBI:"iron chelator") -| p(HGNC:EGLN1)
a(CHEBI:"iron chelator") -| p(HGNC:EGLN3)
a(CHEBI:"iron chelator") -> r(HGNC:HIF1A)

SET Evidence = "At the transcriptional level, oxygen availability enables hydroxylation of the
asparagine residue 803 in the C-TAD of HIF-1α by factor inhibiting HIF (FIH-1),
which blocks the association of HIF-1α with transcriptional co-activators CBP/
p300 and thus inhibits its transcriptional activity [20]."
composite(p(HGNC:HIF1AN),a(CHEBI:dioxygen)) -> p(HGNC:HIF1A,pmod(Hy,Asn,803))
p(HGNC:HIF1A,pmod(Hy,Asn,803)) -| complex(p(HGNC:HIF1A),p(HGNC:CREBBP))
p(HGNC:HIF1A,pmod(Hy,Asn,803)) -| complex(p(HGNC:HIF1A),p(HGNC:EP300))
p(HGNC:HIF1A,pmod(Hy,Asn,803)) -| tscript(p(HGNC:CREBBP))
p(HGNC:HIF1A,pmod(Hy,Asn,803)) -| tscript(p(HGNC:EP300))

SET Evidence = "K532 acetylation by the ARrest-Defective-1 (ARD-1) enhances the interaction between HIF-1α and pVHL
and, thus, leads to increased ubiquitination and concomitant proteasomal degradation [21]."
p(HGNC:NAA10) -> p(HGNC:HIF1A,pmod(Ac,Lys,532))
p(HGNC:HIF1A,pmod(Ac,Lys,532)) -> complex(p(HGNC:VHL),p(HGNC:HIF1A))
p(HGNC:NAA10) -> complex(p(HGNC:VHL),p(HGNC:HIF1A))
complex(p(HGNC:VHL),p(HGNC:HIF1A)) -> deg(p(HGNC:HIF1A))
p(HGNC:NAA10) -> deg(p(HGNC:HIF1A))

SET Evidence = "Mutation of lysine 532 to arginine has been reported to result in increased stability of overexpressed HIF-1α [22]."
p(HGNC:HIF1A,var("p.Lys532?")) -> p(HGNC:HIF1A)

SET Evidence = "Direct phosphorylation on threonine 796 by mitogen-activated protein kinase
(MAPK) has recently been identified as a novel modification on HIF-1α and is able
to increase HIF-1 activity [23]."
p(HGNCGENEFAMILY:"Mitogen-activated protein kinases") -> p(HGNC:HIF1A,pmod(Ph,Thr,796))
p(HGNCGENEFAMILY:"Mitogen-activated protein kinases") -> act(complex(MESH:"Hypoxia-Inducible Factor 1"))

SET Evidence = "One mechanism to explain the increased transcriptional activity is that HIF-1β binds preferentially to the phosphorylated form of HIF-1α [24]."
p(HGNC:HIF1A,pmod(Ph,Thr,796)) -> complex(p(HGNC:HIF1A),p(HGNC:ARNT))

SET Evidence = "Moreover, it has been reported that phosphorylation at T796
in HIF-1α increases the affinity of the interaction between HIF-1α and the
transcriptional co-activator CBP/p300 [25]."
p(HGNC:HIF1A,pmod(Ph,Thr,796)) -> complex(p(HGNC:HIF1A),p(HGNC:CREBBP))
p(HGNC:HIF1A,pmod(Ph,Thr,796)) -> complex(p(HGNC:HIF1A),p(HGNC:EP300))

SET Evidence = "Consistent with this, it is found that
phosphorylation of T796 prevents the hydroxylation of N803 by FIH [25]."
p(HGNC:HIF1A,pmod(Ph,Thr,796)) -| act(p(HGNC:HIF1AN))
p(HGNC:HIF1A,pmod(Ph,Thr,796)) -| p(HGNC:HIF1A,pmod(Hy,Asn,803))

SET Evidence = "Inhibition of these phosphorylation sites has been shown to impair both
transcriptional activity and the nuclear localization of HIF-1α [26]."
p(HGNC:HIF1A,pmod(Ph,Thr,796)) -> tscript(p(HGNC:HIF1A))
p(HGNC:HIF1A,pmod(Ph,Thr,796)) -> tloc(p(HGNC:HIF1A),fromLoc(GO:cytoplasm),toLoc(GO:nucleus))

SET Evidence = "In addition, phosphorylation of HIF-1α by glycogen synthase kinase (GSK)-3β may target
HIF-1α for proteasomal degradation [26]."
p(HGNC:GSK3B) -> p(HGNC:HIF1A,pmod(Ph))
act(p(HGNC:HIF1A,pmod(Ph)),ma(GO:"proteasome binding")) -> deg(p(HGNC:HIF1A))

SET Evidence = "Hydroxyl radical and hydrogen peroxide can destabilize
HIF-1α protein in both normoxic and hypoxic conditions [27–28]."
a(CHEBI:hydroxyl) -| p(HGNC:HIF1A)
a(CHEBI:"hydrogen peroxide") -| p(HGNC:HIF1A)

SET Evidence = "The oxidized HIF-1α protein might be recognized and degraded by the ubiquitin-independent
20S proteasomal pathway, which primarily degrades cellular oxidized proteins under oxidative stress conditions [29]."
#C13737 - 20S Proteasome
p(HGNC:HIF1A,pmod(NCIT:C16944)) -> complex(p(HGNC:HIF1A),a(NCIT:C13737))
complex(p(HGNC:HIF1A),a(NCIT:C13737)) -> deg(p(HGNC:HIF1A))

SET Evidence = "Moreover, studies have revealed
that S-nitrosation stabilizes HIF-1α protein and S-nitrosation of cysteine 800 of
HIF-1α promotes its interaction with CBP/p300, thus enhancing HIF-1α activation
[30]."
p(HGNC:HIF1A,pmod(NO)) -> p(HGNC:HIF1A)
p(HGNC:HIF1A,pmod(NO,Cys,800)) -> complex(p(HGNC:HIF1A),p(HGNC:CREBBP))
p(HGNC:HIF1A,pmod(NO,Cys,800)) -> complex(p(HGNC:HIF1A),p(HGNC:EP300))
p(HGNC:HIF1A,pmod(NO,Cys,800)) -> act(p(HGNC:HIF1A))

SET Evidence = "Sumoylation of HIF-1α has been reported to regulate its protein level and
transcriptional activity."
p(HGNC:HIF1A,pmod(Sumo)) reg r(HGNC:HIF1A)
p(HGNC:HIF1A,pmod(Sumo)) reg tscript(p(HGNC:HIF1A))

SET Evidence = "Increasing the activity of RWD-containing sumoylation
enhancer (RSUME) could promote the sumoylation of HIF-1α by Ubc9 SUMO
conjugase and stabilize HIF-1α during hypoxia [32]."
bp(GO:"response to hypoxia") -> act(p(HGNC:RWDD3))
act(p(HGNC:RWDD3)) -> act(p(HGNC:UBE2I))
p(HGNC:UBE2I) -> p(HGNC:HIF1A,pmod(Sumo))
p(HGNC:HIF1A,pmod(Sumo)) -> p(HGNC:HIF1A)

SET Evidence = "However, desumoylation by
SUMO-Specific Protease 1 (SENP-1) has been shown to be essential for the
stabilization of HIF-1α [33]."
p(HGNCGENEFAMILY:"SUMO specific peptidases") -| p(HGNC:HIF1A,pmod(Sumo))
p(HGNCGENEFAMILY:"SUMO specific peptidases") reg p(HGNC:HIF1A)

SET MeSHDisease = "Amyotrophic Lateral Sclerosis"

SET Evidence = ""
